How does iron deficiency impair thyroid function?

How it works

Hess 2002 (J Nutr 132(7):1951-1955, PMID 12097675) showed 33-56% reductions in TPO activity in iron-deficient rats versus iron-replete controls (with both iron deficiency and food restriction contributing as independent predictors by multiple regression). Beyond TPO, iron is also required for the deiodinase enzymes that convert T4 to active T3 in peripheral tissues, although the magnitude of this contribution to circulating T3 in iron deficiency is less clearly quantified.

Safety profile

Specific thyroid-related ferritin targets (such as a target of 70 µg/L) are not currently codified in mainstream endocrinology guidelines (AACE/ATA 2012 hypothyroidism guidelines, BSG 2021, NICE) and should not be presented as established standards. The TPO mechanism is well-established mechanistically but the effect size of correcting iron deficiency on thyroid hormone levels in iron-replete individuals with mild iron insufficiency is modest. Pregnancy considerations require specific clinical review.

Special populations

Iron deficiency itself can modestly alter the thyroid panel (lower FT4 and FT3 with normal-range TSH per Garofalo 2023), so a thyroid panel obtained during active iron deficiency may not reflect steady-state thyroid function once iron is repleted; repeat thyroid testing after iron repletion can be informative. Symptoms of iron deficiency and thyroid hypofunction overlap substantially: fatigue and reduced exercise tolerance; cold intolerance; cognitive symptoms; hair thinning or loss; dry skin; mood symptoms; menstrual irregularity. The symptom overlap is the rationale for testing both ferritin and a thyroid panel together.

Interactions

Standard iron interactions also apply: calcium, polyphenols, antacids, and PPIs reduce iron absorption when concurrent. The "iron first then reassess thyroid" sequencing rule that appears in some online protocols is not a definitive evidence-based pathway. What gets corrected first depends on which is most deficient by lab values, which symptoms are most prominent, and what medications are involved.

Guideline positions

Garofalo 2023 included studies in pregnant women, non-pregnant women, and other adult populations: iron-deficient pregnant women showed significantly lower TSH, FT4, and FT3 than iron-replete controls; non-pregnant women had lower FT4 and FT3 with TSH within normal range; iron deficiency was significantly more common in individuals with elevated anti-thyroid antibodies. Eftekhari 2006 trial in iron-deficient adolescent girls: iron supplementation accompanied improvement in thyroid hormone indices; iron-only and iron-plus-iodine groups did not differ from each other but both differed significantly from iodine-only and placebo groups, supporting a specific role for iron repletion. AACE/ATA 2012 hypothyroidism guidelines remain the reference standard for thyroid hormone replacement.

Practical framework

Where iron deficiency is severe (Hb low or ferritin below 30 with symptoms), iron correction first is reasonable; where Hashimoto thyroiditis with overt hypothyroidism is established, levothyroxine replacement is first-line. Clinical sequencing is genuinely individualised. When iron deficiency and subclinical thyroid abnormalities co-exist, current evidence suggests addressing iron deficiency may improve thyroid hormone indices in some individuals; however, RCT evidence specifically comparing iron-first vs thyroid-first vs combined approaches in adults with both conditions is limited. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: a single normal-range thyroid panel during iron deficiency rules out thyroid involvement. Iron deficiency itself can modestly alter the thyroid panel; repeat testing after iron repletion can be informative.

Claim: "iron first then reassess thyroid" is the universal sequencing rule. The actual sequencing depends on which is most deficient, which symptoms are most prominent, and what medications are involved. RCT evidence comparing sequencing approaches is limited.